Şaziye Betül Sopacı is an Assistant Professor at Kirşehir Ahi Evran University , affiliated with the Faculty of Arts and Sciences and the Department of Chemistry . Her work spans Biochemistry , Biotechnology , and Nanotechnology . PhD in Biotechnology from Middle East Technical University (2008–2011) MSc in Biotechnology from Middle East Technical University (1997–2000) BSc in Chemistry from Hacettepe University (1990–1994) Her research focuses on biochemical reactions , nanostructured materials , and antimicrobial applications . Recent work includes adsorption studies , chemo-enzymatic synthesis , and nanoparticle-based bioremediation . Publications cover thermal kinetics , metal adsorption , and nanoparticle-enzyme systems . She collaborates with researchers across institutions, including Middle East Technical University , Kütahya Dumlupınar University , and Ankara University . Metrics include 28 citations , an h-index of 4 , and 11 journal articles . Projects involve nanocomposite synthesis and energetic material development .
Vivek Garg serves as Assistant Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine, where he leads research on mitochondrial calcium signaling mechanisms and their physiological implications. His work bridges molecular biophysics with cardiovascular pathophysiology, utilizing innovative electrophysiological approaches to investigate fundamental cellular processes. Education: B.Pharmacy in Pharmacology, Panjab University, India (1999) M.Pharmacy in Pharmacology, Panjab University, India (2002) Ph.D. in Pharmacology, The Ohio State University (2009) Postdoctoral Fellowship, University of Utah (2014) Researcher Position, University of California San Francisco (2020) Dr. Garg's research centers on mitochondrial bioenergetics and membrane excitability, with particular emphasis on the molecular physiology of mitochondrial calcium uniporter (MCU) complexes. His laboratory employs direct patch-clamp techniques on intracellular organelles combined with cell biology and multi-omics approaches to decipher how mitochondrial calcium signaling regulates cellular metabolism and electrical activity. This work has significant implications for understanding heart failure, metabolic disorders, and other conditions involving mitochondrial dysfunction. Analysis of his publication record reveals a consistent trajectory from cardiac ion channel research toward specialized mitochondrial electrophysiology. His recent work demonstrates technical innovation in organelle patch-clamp methodology while establishing critical regulatory mechanisms for MCU through EF-hand domain proteins. The publications span fundamental biophysical characterization to disease-relevant models, particularly focusing on cardiac pathophysiology and metabolic plasticity. Scientific Awards: No scientific awards documented in provided materials Dr. Garg currently serves as Principal Investigator on a National Institute of General Medical Sciences R01 grant (2023-2027) titled 'Molecular Physiology of Mitochondrial Calcium Uniporter (MCU)', reflecting the significance of his research program. While no formal advisees are listed in the provided documentation, he directs the Garg Lab which maintains active research operations focused on mitochondrial function. The Garg Lab operates within the Department of Pharmacology & Physiology, utilizing specialized equipment for mitochondrial patch-clamp recordings, confocal imaging, and omics analyses. Their research program investigates how mitochondrial abnormalities contribute to disease states through altered bioenergetics and signaling pathways, with particular attention to calcium and redox homeostasis in cardiac and metabolic contexts.
Dr. Matthew C. Trudeau is a Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine. His research focuses on molecular physiology of ion channels, particularly hERG potassium channels and cyclic nucleotide-gated (CNG) channels. He earned his PhD at the University of Wisconsin-Madison under Dr. Gail Robertson and completed postdoctoral training with Dr. Bill Zagotta at the University of Washington and HHMI. Dr. Trudeau has held continuous NIH funding since 2004 and directs the T32 Training Program in Integrative Membrane Biology. University of Wisconsin-Madison (PhD, 1993-1998) University of Washington/HHMI (Postdoc, 1998-2004) University of Maryland (Assistant Professor 2004-present) His work investigates how intracellular domains regulate ion channel gating, with emphasis on mechanisms underlying cardiac arrhythmias and inherited vision loss. Key discoveries include intersubunit interactions in CNG channels and molecular regulation of hERG deactivation by the eag domain. His lab employs molecular biology, electrophysiology, and fluorescence imaging to study these mechanisms. Recent research trends focus on hERG channel subunit interactions (2022 textbook editorship), structural dynamics of KCNH channels (2021-2013), and therapeutic approaches to channelopathies (2015-2021 grants). His publications span high-impact journals like PNAS, Nature, and Journal of General Physiology. 2014 Paul F. Cranefield Award 2022 Co-Chair, Society of General Physiologists Meeting 2017-2018 NIH Special Emphasis Panel Member 2015-2016 Editorial Advisory Board, Journal of General Physiology Dr. Trudeau's lab trains graduate students through NIH-funded programs and collaborates on multi-institutional research initiatives like M-CERSI. His work bridges fundamental biophysics with translational applications for inherited diseases.
Dr. Divya Tiwari serves as a Barts Charity Lecturer at the Centre for Immunobiology, Blizard Institute, Queen Mary University of London, where she leads research on tuberculosis pathogenesis and host-pathogen interactions in Mycobacterium tuberculosis. Her work focuses on identifying novel drug targets to enhance host immune responses against drug-resistant TB strains, addressing a critical global health challenge. Her academic journey includes a Bachelor of Science and Master of Science in Microbiology from Pt Ravishankar Shukla University, India, a PhD from the National Institute of Immunology, New Delhi, and postdoctoral training at Weill Cornell Medicine, New York. Prior to her current role, she contributed to research administration as a Grants Adviser for The Wellcome Trust DBT India Alliance. Dr. Tiwari's research program centers on tuberculosis mechanisms, particularly how Mtb manipulates host immunity and identifying metabolic pathways like biotinylation and respiratory chain plasticity for therapeutic intervention. Her work bridges fundamental molecular biology and translational drug development to combat persistent and drug-resistant infections. Analysis of her 12 publications (2007-2023) reveals a consistent trajectory in TB drug discovery, with recent emphasis on host-directed therapies (2023) and inflammation-mediated tissue damage, while earlier work established foundational insights into bacterial metabolism targets. This evolution demonstrates progression from molecular mechanisms to clinical applications. She established her independent research group through the Barts Charity Lectureship, leveraging prior grant advisory experience to secure research funding. Her work bridges the Centre for Immunobiology's focus on infectious disease immunity with global TB control efforts. Dr. Tiwari's laboratory operates within the Blizard Institute's Centre for Immunobiology, contributing to collaborative research on immune responses to intracellular pathogens and participating in Queen Mary's strategic initiatives in global health and antimicrobial resistance.
Nicole Baganz, Ph.D., serves as Assistant Director and Director of Community Engagement & Programming at the FAU Stiles-Nicholson Brain Institute, with a secondary appointment as Research Assistant Professor in Biomedical Science at Florida Atlantic University's Charles E. Schmidt College of Medicine. Her research explores immune-brain interactions, focusing on serotonin signaling and its role in mood regulation. B.S., Biology, University of Wisconsin Eau Claire M.S., Traditional Chinese Medicine, Midwest College of Oriental Medicine Ph.D., Physiology/Neuroscience, University of Texas Health Science Center Baganz’s work bridges neuroimmunology and psychiatric research, emphasizing how peripheral immune activation alters serotonin inactivation and mood-related behaviors. She investigates IL-1R/p38 MAPK pathways, translational models of early-life stress, and novel antidepressant targets like organic cation transporters. Her scientific outreach includes public education initiatives and leadership in neuroscience communication programs. Her article trends reveal a sustained focus on serotonin transporter-independent mechanisms, neuroimmune signaling, and translational models of depression. Key journals include PLoS One , Translational Psychiatry , and Journal of Neuroscience . 2015 Society for Neuroscience Next Generation Award 2014–2016 NARSAD Young Investigator Award 2009 Armand J. Guarino University-Wide Thesis Award Baganz has contributed to grants like the Vanderbilt Trans-Institutional Music & Mind program and NIH Ion Channel Training Grant. She mentors community projects, including Harmonies for the Elderly and NAMI walk teams.
Abhinav Mishra is an Associate Professor and Graduate Coordinator in the Department of Food Science & Technology at the University of Georgia’s College of Agricultural & Environmental Sciences. He is based in Athens, GA, and focuses on food microbiology, predictive modeling, and quantitative microbial risk assessment to enhance food safety. Education Specific educational credentials are not detailed in the provided text. Research Interests Mishra’s research centers on: Food microbiology and microbial ecology Predictive modeling of microbial behavior in foods Quantitative microbial risk assessment (QMRA) Food safety interventions and control strategies Survival and persistence of foodborne pathogens across the farm-to-fork continuum His lab develops mathematical models to predict how pathogens like Salmonella , Listeria monocytogenes , and E. coli grow, survive, or decline under varying environmental conditions, enabling data-driven risk management. Teaching He currently teaches: FDST(MIBO) 4120/6120-4120L/6120L: Food Fermentations FDST(EHSC)(MIBO) 4320/6320-4320L/6320L: Food Safety Control Programs FDST 8090: Advanced Food Microbiology Recent Research Trends Over the past decade, Mishra’s publications have increasingly emphasized the integration of predictive models with real-world data to quantify pathogen risks in produce, meat, poultry, and dairy products. His work spans pre-harvest contamination sources, processing interventions, temperature abuse scenarios, and novel antimicrobial technologies such as UV-C and atmospheric cold plasma. A clear trajectory toward data-driven decision-making and risk-based food safety management is evident. Contact & Location Email: amishra@uga.edu Phone: 706-542-0994 Mail & Shipping: Food Science Building, 100 Cedar St., Athens, GA 30602
Riccardo Olcese is a Professor in the Department of Anesthesiology and Perioperative Medicine at the University of California, Los Angeles (UCLA) . He is affiliated with multiple graduate programs, including Molecular Medicine, Biochemistry, Biophysics & Structural Biology , and the Cardiovascular Research Laboratory . His research focuses on the biophysical properties of ion channels, particularly voltage- and calcium-dependent mechanisms in cardiac and neuronal systems. Research Interests : Biophysics of ion channels, voltage sensor dynamics, calcium signaling, cardiac arrhythmias, molecular mechanisms of anesthesia, and mitochondrial channel regulation. Publications highlight his work on BK and CaV channel modulation, fibroblast-driven cardiac arrhythmogenesis, and novel therapeutic strategies for epilepsy and atrial fibrillation. His lab employs advanced techniques like voltage-clamp fluorometry and computational modeling to dissect channelopathies in cardiovascular and neurological diseases.
Corey M. Johnson is an Associate Professor at Samford University within the Howard College of Arts and Sciences, Department of Chemistry and Biochemistry. He joined Samford in 2012 after serving as an American Heart Association Research Fellow at the Oklahoma Medical Research Foundation and a Senior Research Fellow in Medicinal Chemistry at the University of Texas at Austin. BS, Chemistry, East Central University, 1998 PhD, Biochemistry, University of Oklahoma, 2004 Johnson's research focuses on the functional characterization of enzymes, particularly their kinetic mechanisms and catalytic pathways. His lab investigates Tetrahydrodipicolinate N-succinyltransferase (DapD) as a potential antibiotic target for bacterial lysine biosynthesis and explores industrial and environmental applications of laccase in wastewater pollutant degradation. Techniques include kinetic analysis, substrate specificity testing, pH dependence studies, inhibition assays, and mutation effects. His recent work on laccase involves collaborative biosensor and biofuel cell development, reflecting a broader interest in applying enzymatic catalysis to environmental and industrial challenges. Publications highlight expertise in enzyme kinetics, mechanism elucidation, and therapeutic target identification. American Heart Association Research Fellow Senior Research Fellow in Medicinal Chemistry, University of Texas at Austin Johnson's lab integrates molecular biology, protein purification, and spectroscopic methods to train students in essential biochemical techniques. He also emphasizes interdisciplinary collaboration and practical applications of enzymatic research.
Kirsi Virtanen serves as Assistant Professor (Phase II) at the University of Turku's PET Center, where she leads research at the intersection of endocrinology, metabolism, and advanced imaging. Her work focuses on human metabolic physiology with emphasis on adipose tissue biology, obesity mechanisms, and liver disease pathogenesis. Research interests center on brown adipose tissue thermogenesis , gut-liver-metabolite interactions , and metabolic imaging . She investigates how short-chain fatty acids serve as brown fat biomarkers, how cryotherapy impacts obesity management, and the role of lymphoid structures in adipose tissue inflammation. Her methodology combines clinical PET imaging with molecular metabolomics to dissect metabolic pathways in human disease. Analysis of her 2024-2025 publications reveals a strong translational trajectory, with 9 high-impact papers spanning original clinical research, imaging methodology, and mechanistic reviews. Key trends include growing emphasis on microbiome-derived metabolites in metabolic disease, refinement of PET techniques for metabolic phenotyping, and expansion into immunometabolism through lymphoid-adipose tissue crosstalk studies. Dr. Virtanen maintains active international collaborations across Europe and North America, particularly in obesity genetics and imaging methodology. Her clinical trial work suggests strong grant support for human metabolic studies, and she likely supervises graduate students in endocrinology and nuclear medicine. Prospective researchers should contact her directly regarding lab opportunities in metabolic imaging and translational obesity research.
Dr. Carl C. Correll serves as Associate Professor in the Department of Biochemistry and Molecular Biology at Rosalind Franklin University's Chicago Medical School, with dual appointments in the School of Graduate and Postdoctoral Studies and the Center for Proteomics and Molecular Therapeutics. His research centers on ribosome biogenesis mechanisms, specifically the dynamic RNA-protein interactions governing pre-ribosomal assembly. The lab investigates how the DEAH helicase Dhr1 dislodges U3 snoRNA from pre-ribosomes—a process critical for ribosome maturation and emerging as a cancer therapeutic target—and how regulators like Utp14 control Dhr1 activity. These studies combine biochemical, genetic, and structural approaches to unravel fundamental cellular processes. Dr. Correll's publication record spans two decades with consistent output in high-impact journals including PLOS Biology, Molecular and Cellular Biology, and Nature Structural & Molecular Biology. His work shows a clear trajectory from structural RNA biochemistry (early 2000s) toward mechanistic dissection of ribosome assembly factors, with increasing focus on cancer-relevant pathways since 2015. Scientific recognition includes: American Cancer Society Postdoctoral Fellowship Dr. Correll mentors PhD students and postdocs, with alumni securing positions at Scripps Florida, Winthrop University, and industry roles. Current projects examine Dhr1 regulation by Utp14 and Imp3/Imp4 control by Mpp10, supported through institutional resources and collaborations with Dr. Johnson's lab at UT Austin. The lab operates within Rosalind Franklin's Center for Proteomics and Molecular Therapeutics, providing access to advanced biochemical and molecular facilities for studying RNA-protein dynamics with direct implications for ribosomopathy-related diseases.
Gabi Daniel Stancu is a Professor at CentraleSupélec/University Paris-Saclay, France, and Deputy Director of the EM2C Laboratory (CNRS UPR288). His research focuses on advanced laser diagnostics for plasmas, including techniques like CRDS, TALIF, and QCLAS, applied to reactive plasmas, combustion, and biomedical systems. He coordinates Master's programs in Thermoscience and Energy, and has developed e-learning platforms for heat transfer education. Research interests span: Plasma diagnostics : UV-Mid-IR laser spectroscopy, time/space-resolved measurements Fundamental mechanisms : Kinetics in nanosecond/capillary discharges Applications : Combustion enhancement, biomedical decontamination Publications emphasize laser-based diagnostics, plasma kinetics, and hydrodynamic effects in atmospheric discharges, with consistent focus on quantitative species detection and energy transfer. Awards: Premier Prix 'Impact Science' (2021) French Ministry Research Excellence Award (2011-2020) Innolec Lectureship (2013) Supervised 8 PhD students and 7 postdocs. Leads plasma diagnostics research at EM2C Lab with international collaborations (Stanford, Princeton).
Peter Ratcliffe is a distinguished physician-scientist and Nobel Laureate currently serving as Director of Clinical Research at the Francis Crick Institute since 2016, while maintaining an active position at the University of Oxford as Director of the Target Discovery Institute and member of the Ludwig Institute of Cancer Research. Previously, he was Nuffield Professor of Clinical Medicine and Head of the Nuffield Department of Clinical Medicine at Oxford from 2004-2016. His career spans decades of groundbreaking research in oxygen sensing mechanisms and hypoxia biology, beginning with his medical training at Gonville and Caius College, Cambridge and St. Bartholomew's Hospital, London. His research interests focus on the molecular mechanisms of oxygen sensing, particularly the HIF (hypoxia inducible factor) pathway and protein hydroxylation. Ratcliffe's laboratory has made fundamental discoveries about how cells sense and adapt to changes in oxygen availability, demonstrating that the oxygen sensing process operates across virtually all animal cells and directs a broad range of cellular and systemic responses to hypoxia including altered energy metabolism, angiogenesis, and cell survival/differentiation decisions. His current work aims to understand the biological roles of signaling through protein hydroxylation and related oxidations, linking these biochemical pathways to physiological control and the pathophysiology of human diseases including cancer and ischemic vascular disease. Analysis of Ratcliffe's recent publications (2022-2025) reveals a continued focus on the HIF pathway and oxygen sensing mechanisms across multiple biological contexts. His research spans cancer biology (particularly kidney cancer), developmental biology, immunology, and neuroscience, with particular emphasis on how oxygen sensing pathways interact with other cellular systems. Recent work has expanded into single-cell transcriptomics, tumor heterogeneity, immune microenvironment interactions, and the application of these findings to potential therapeutic approaches. Fellowship of the Royal Society (2002) Academy of Medical Sciences (2002) Member of EMBO Foreign honorary member of the American Academy of Arts and Sciences Louis-Jeantet Prize in Medicine Canada Gairdner International Award Lasker Award for Basic Biomedical Research Knighted for services to medicine (2014) Nobel Prize in Physiology or Medicine (2019) Ratcliffe has led the Hypoxia Biology laboratory since establishing it in 1990 at the Weatherall Institute of Molecular Medicine, Oxford, with funding as a Wellcome Trust Senior Fellow. His research has been consistently supported by major funding bodies including the Wellcome Trust, and his work has had significant translational impact. While specific grant amounts aren't detailed in the provided text, his leadership roles at major institutions and the volume of high-impact publications suggest substantial research support. His laboratory has trained numerous scientists who have gone on to make their own contributions to the field, though specific student names aren't provided in the source material. Ratcliffe's primary research base is the Hypoxia Biology laboratory, which he established at the Weatherall Institute of Molecular Medicine in Oxford in 1990. Currently, his research continues through his role as Director of Clinical Research at the Francis Crick Institute, where he collaborates with numerous research groups across multiple disciplines. His work involves extensive collaborations with researchers in biochemistry, cell biology, oncology, and physiology, as evidenced by his co-authorship on papers spanning these fields. The laboratory's research integrates molecular, cellular, and physiological approaches to understand oxygen sensing mechanisms and their implications for human health and disease.
Vicenç Marti Gregorio is an Associate Professor in the Department of Chemical Engineering at the School of Engineering of Eastern Barcelona (EEBE), Universitat Politècnica de Catalunya (UPC). His research focuses on environmental risk assessment, contaminated sediments and waters, environmental technology, and soil treatment. He is actively involved in the R2EM (Resource Recovery and Environmental Management) research group and the CCEM (Centre de Recerca en Ciència i Enginyeria Multiescala de Barcelona). Dr. Marti Gregorio holds a Doctorate in Industrial Engineering with a Chemical Specialty, along with degrees as an Industrial Engineer and Technical Industrial Engineer, both with Chemical Specialties. His research spans multiple areas of environmental engineering with a particular focus on water and soil treatment technologies. His recent research has centered on environmental risk assessment of nanoparticles, particularly silver nanoparticles, in aquatic ecosystems; development of novel adsorbents for heavy metal removal from water; and creation of advanced electrochemical sensors for environmental monitoring. His work integrates chemical engineering principles with environmental science to develop practical solutions for water and soil remediation challenges. The publication trends show strong emphasis on sustainable resource recovery, nanotechnology applications, and environmental risk assessment methodologies. Dr. Marti Gregorio has collaborated extensively with researchers across multiple institutions, with particularly strong collaborations with Joan de Pablo Ribas (79 collaborations), Jose Luis Cortina Pallas (46), and Miguel Arcangel Rovira Boixaderas (38). His research has resulted in numerous publications in high-impact journals related to environmental engineering and water treatment, with 55 indexed journal articles among his 169 total research activities. He has supervised doctoral students including Karina Alejandra Torres-rivero, who completed research on nano-enabled screen-printed electrodes for trace element determination, and R. Ramirez, who conducted research on nanoparticle environmental risk assessment. His research aligns with Sustainable Development Goals 6 (Clean Water and Sanitation) and 9 (Industry, Innovation and Infrastructure).
Marina Lotti is a Full Professor of Biochemistry at the University of Milano-Bicocca's Department of Biotechnology and Biosciences, where she leads the Laboratory of Protein Engineering and Industrial Enzymology. She serves on the University Board and maintains collaborations with institutions including Hebrew University of Jerusalem, University of Stuttgart, State University of Milano, and University of Camerino. Her research encompasses: Biocatalysis : Enzyme design and optimization for industrial processes Psychrophilic Proteins : Cold-active enzymes and antifreeze proteins from Antarctic organisms Protein Dynamics : Folding, misfolding, and aggregation mechanisms in recombinant proteins She directs educational initiatives including the European Summer School of Industrial Biotechnology and UNIMIB's 'Towards a Bio-based Economy' program, emphasizing interdisciplinary science education.
Klaudiusz Grübel is a Professor at the University of Bielsko-Biała's Faculty of Civil, Material and Environmental Science, where he has been employed since 2001. He holds a DSc from Silesian University of Technology (2016), a PhD from Czestochowa University of Technology (2008), an MSc from University of Bielsko-Biala (2003), and an Engineering degree from Lodz University of Technology (2001). His research specializes in environmental engineering solutions, with emphasis on: Advanced wastewater and sludge treatment technologies Anaerobic digestion optimization for biogas production Heavy metal remediation and resource recovery Innovative sludge disintegration techniques (cavitation, alkaline, thermal) Energy management in industrial and municipal systems Grübel maintains a robust publication record with recent works demonstrating strong focus on: circular economy applications in waste management, process intensification for biogas yield, advanced oxidation processes, and risk mitigation in water infrastructure. His articles frequently appear in high-impact journals like Energies , Chemical Engineering Journal , and Environmental Science and Pollution Research . He collaborates extensively with European research institutions and industry partners, though no dedicated lab or research group is explicitly mentioned in available sources.
